I’m interested in biological markers of brain function and structure that can be used to characterise psychosis. In particular, I have expertise in using EEG techniques like evoked potentials and quantitative EEG and have also worked with structural imaging and cognitive biomarkers for psychosis.

I moved to UCL to develop a new programme applying EEG analysis methods to investigate brain dysfunction underlying genetic vulnerability towards psychosis. While EEG and other imaging biomarkers are important in themselves to understand the pathophysiology of the disease, ultimately I use them as alternative phenotypes to explore the mechanisms through which genetic variants influence the risk of developing psychosis.